Christina Teng Topsoe - Jun 30, 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director, 10%+ Owner
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Jun 30, 2023
Transactions value $
$27,957
Form type
4
Date filed
7/5/2023, 09:07 PM
Previous filing
Jun 28, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $28K +3K +44.12% $9.32 9.8K Jun 30, 2023 See footnote F1, F2
transaction IGMS Common Stock Award $0 +738 +1.91% $0.00 39.4K Jun 30, 2023 Direct F3
holding IGMS Common Stock 10.4M Jun 30, 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $9.31 to $9.34. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
F2 The shares are held by Pillarcater LLC. The Reporting Person is the sole manager of Pillarcater LLC, which is wholly owned by CT Foundation (a South Dakota Trust) of which the Reporting Person is the sole beneficiary.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F4 The shares are held directly by Topsoe Holding A/S (formerly Haldor Topsoe Holding A/S). Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.